Recombinant proteins play a critical role in the rapid detection of SARS-CoV-2, the virus responsible for COVID-19. These proteins ensure a consistent and standardized source of viral antigen, which is vital for accurate test results. Using recombinant proteins in rapid tests enables standardization, ensuring reliable and comparable results between different tests. The speed and accuracy of SARS-CoV-2 diagnosis is crucial in controlling the spread of the virus. That's why Leadgene offers a comprehensive collection of high-quality recombinant proteins for the development of COVID-19 rapid tests. Get access to the essential tools you need to tackle the ongoing pandemic with confidence.
LEADGENE® SARS-CoV-2 Spike Protein RBD (Delta B1.617.2 Variant), Tag Free, HEK293
LEADGENE® SARS-CoV-2 Spike Protein RBD (Omicron B1.1.529 Variant), Tag Free, HEK293
LEADGENE® SARS-CoV-2 Nucleocapsid Protein (Omicron B1.1.529 Variant), Tag Free, HEK293
HEK293
LEADGENE® SARS-CoV-2 Nucleocapsid Protein (IHU B.1.640.2 Variant), Tag Free
Escherichia coli
LEADGENE® SARS-CoV-2 Nucleocapsid Protein (Omicron B1.1.529 Variant), Tag Free
Escherichia coli
LEADGENE® SARS-CoV-2 Trimeric Spike Protein (Delta B1.617.2 Variant), His Tag, HEK293
HEK293
LEADGENE® SARS-CoV-2 Trimeric Spike Protein (Beta B1.351 Variant), His Tag, HEK293
HEK293
LEADGENE® SARS-CoV-2 Trimeric Spike Protein, His Tag, HEK293
HEK293